SUNMO Trial: A New Chapter for Transplant-Ineligible Large B-Cell Lymphoma

CVC and V Foundation Fuel $500K Grant for Next Phase of HER2+ Breast Cancer Vaccine Research

The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines

ONCOLife’s New Edition Is Live with Breakthroughs in Cancer Research

FDA Grants Breakthrough Status to Izalontamab Brengitecan for EGF+ Lung Cancer

The First FDA-Cleared Blood Test for Alzheimer’s Diagnosis Now Available on the Market

First Patient Enrolled for Aliya® PEF Tumor Ablation of Lung/Liver Soft-Tissue Lesions

Ferroptosis as a New Strategy: Iron-Driven Cell Death Targets Cancer Stem Cells

Bacteria Cloak Viruses to Safely Deliver Cancer-Killing Payloads into Solid Tumors

FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis

RNA Isoform RUNX1C Identified as Molecular 'Switch' Behind Chemoresistance in Blood Cancer

FDA Approves Papzimeos, First Immunotherapy for Recurrent Respiratory Papillomatosis

mRNA Vaccines Plus Checkpoint Inhibitors Shows Curative Potential in Gastric Cancer

Redesigned CD40 Antibody Triggers Systemic Tumor Regression and Complete Remission

Breaking the Molecular Link Between Alcohol and Pancreatic Cancer by Targeting CREB

PADCEV–KEYTRUDA Combination Delivers Survival Gains in High-Risk Bladder Cancer

Genetic Testing Boosts Safety, Reduces Chemotherapy Side Effects in GI Cancer

FDA Grants Fast Track Designation to Birelentinib for Relapsed/Refractory CLL and SLL

Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR

Epcoritamab + R2 Achieves 95.7% ORR, Cuts Risk by 79% in R/R Follicular Lymphoma

FDA Approves Modeyso as First-Ever Therapy for Pediatric Brain Tumor, H3 K27M+ Glioma

FDA Fast-Tracks Breyanzi as First CAR T Cell Therapy for Marginal Zone Lymphoma

Novel Viral Immunotherapy SuperNova Gains FDA Fast Track Designation for Sarcoma

2025 Pan-Mass Challenge Draws Thousands of Cyclists to Fuel Next Era of Cancer Research

Targeting eIF2A to Halt Melanoma: Study Reveals Key Driver of Cancer Cell Migration

New Study Uncovers Hidden Disease in 42% of Ovarian Cancer Patients in Remission

Dr. Iris Kuss: ARANOTE Trial Results Signal a New Era in Prostate Cancer Treatment

New Radioimmunotherapy Strategy Eradicates Cancer Stem Cells in Ovarian Cancer

First Non-Invasive Endometrial Cancer Detection Test, EdenDx, Launched by Gnosis

Artificial Sweetener Sucralose May Undermine Cancer Immunotherapy, Study Finds